Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 1;105(4):999–1012. doi: 10.3324/haematol.2018.207001

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright© 2020 Ferrata Storti Foundation

Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions:

https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions:

https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.

PMC Copyright notice

Figure 2. — Association of CD99 expression with patients’ clinical characteristics in acute myeloid leukemia (AML) datasets. (A) Relative expression of CD99 according to the National Comprehensive Cancer Network (NCCN) risk status classification in the The Cancer Genome Atlas (TCGA) dataset. (B) Overall survival (OS) of 173 patients grouped based on CD99 median expression into CD99 high (n=87) and CD99 low (n=86) from the TCGA dataset. (C) OS of cytogenetically abnormal (CA-AML) cases grouped based on CD99 median expression into CD99 high (n=42) and CD99 low (n=42). (D) OS of 146 patients grouped based on ENST00000381192.10 transcript isoform based on median expression into high (n=123) and low (n=123) from the GSE106291 dataset. (****P<0.0001; ** P<0.01).